Announced Thu, 25 Jun · 16:32 IST
Trading window closure for Q1 FY27 results
Compliance View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-0.4%1-day move
₹39.75
prior close
₹39.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
—+4.5+3.1—-0.4+0.1+0.6+0.5-0.8-5.4-12.9———
Up moveDown movePending
AI summary
Bacil Pharma has informed BSE that the trading window for designated persons will be closed from 1 July 2026 until 48 hours after the board meeting concludes. The board will meet to consider and approve the unaudited financial results for the quarter ended 30 June 2026. This is a routine insider trading compliance measure under SEBI regulations and indicates that the Q1 results announcement is expected soon.
Likely market impact
Routine compliance filing with no material impact. Signals upcoming Q1 FY27 results declaration by the company in coming weeks.